Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Li, Yun R ^a,b   van Setten, Jessica ^c   Verma, Shefali S ^f   Lu, Yontao ^d   Holmes, Michael V ^e   Gao, Hui ^b,e   Lek, Monkol ^g,h   Nair, Nikhil ^b,e   Chandrupatla, Hareesh ^b,e   Chang, Baoli ^b,e   Karczewski, Konrad J ^g,h   Wong, Chanel ^b,e   Mohebnasab, Maede ^b   Mukhtar, Eyas ^b,e   Phillips, Randy ^b,e   Tragante, Vinicius ^c   Hou, Cuiping ^b   Steel, Laura ^b,e   Lee, Takesha ^b,e   Garifallou, James ^b   Guettouche, Toumy ^b   Cao, Hongzhi ^i,j   Guan, Weihua ^k   Himes, Aubree ^b,e   van Houten, Jacob ^b   Pasquier, Andrew ^b   Yu, Reina ^b   Carrigan, Elena ^b   Miller, Michael B ^k   Schladt, David ^u   Akdere, Abdullah ^a   Gonzalez, Ana ^a   Llyod, Kelsey M ^a   McGinn, Daniel ^a   Gangasani, Abhinav ^a   Michaud, Zach ^a   Colasacco, Abigail ^a   Snyder, James ^b   Thomas, Kelly ^b   Wang, Tiancheng ^b   Wu, Baolin ^k   Alzahrani, Alhusain J ^t   Al Ali, Amein K ^l   Al Muhanna, Fahad A ^l   Al Rubaish, Abdullah M ^l   Al Mueilo, Samir ^l   Monos, Dimitri S ^b   Murphy, Barbara ^m   Olthoff, Kim M ^e   Wijmenga, Cisca ⁿ   Webster, Teresa ^d   Kamoun, Malek ^b   Balasubramanian, Suganthi ^o   Lanktree, Matthew B ^e   Oetting, William S ^k   Garcia Pavia, Pablo ^p   MacArthur, Daniel G ^g,h   de Bakker, Paul I W ^c   Hakonarson, Hakon ^b   Birdwell, Kelly A ^q   Jacobson, Pamala A ^k   Ritchie, Marylyn D ^f   Asselbergs, Folkert W ^c,r,s   Israni, Ajay K ^k   Shaked, Abraham ^e   Keating, Brendan J ^e,v   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Thermo Fisher Scientific   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f PENNSYLVANIA STATE UNIVERSITY   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ BGI SHENZHEN   (China)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k UNIVERSITY OF MINNESOTA   (United States)

^l IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^m MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^o YALE UNIVERSITY   (United States)

^p HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^q VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^s UNIVERSITY COLLEGE LONDON   (United Kingdom)

^t KING SAUD UNIVERSITY   (Saudi Arabia)

^u MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^v UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENETIC ASSOCIATION; GENETIC INCOMPATIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HERITABILITY; HUMAN; MEASUREMENT ACCURACY; NATURAL KILLER CELL; PARENT PARENT CHILD HERITABILITY; PHARMACOGENOMICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSPLANTATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

DNA COPY NUMBER VARIATIONS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA ANTIGENS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, KIR;

EID: 84942757746     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-015-0211-x     Document Type: Article

References (54)

1. Organ Procurement and Transplantation Network. Available at: http://optn.transplant.hrsa.gov.
2. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. J Heart Lung Transplant. 2010;29:1089-103.
3. Burton CM, Iversen M, Carlsen J, Mortensen J, Andersen CB, Steinbrüchel D, et al. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. J Heart Lung Transplant. 2009;28:888-93.
4. Terasaki PI. Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. Clin Transpl. 2003;449-52.
5. Kaplan B, Qazi Y, Wellen JR. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev (Orlando). 2014;28:126-33.
6. Hornum M, Lindahl JP, von Zur-Mühlen B, Jenssen T, Feldt-Rasmussen B. Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl Int. 2013;26:1049-60.
7. McCarthy MI, Hirschhorn JN. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet. 2008;17:R156-65.
8. Peiffer DA, Gunderson KL. Design of tag SNP whole genome genotyping arrays. Methods Mol Biol. 2009;529:51-61.
9. International HapMap Consortium. The International HapMap Project. Nature. 2003;426:789-96.
10. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-73.
11. Gratwohl A, Döhler B, Stern M, Opelz G. H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet. 2008;372:49-53.
12. Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, et al. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med. 2015;367:805-16.
13. Vampa ML, Norman PJ, Burnapp L, Vaughan RW, Sacks SH, Wong W. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch. Transplantation. 2003;76:1220-8.
14. Tan JC, Kim JP, Chertow GM, Grumet FC, Desai M. Donor-recipient sex mismatch in kidney transplantation. Gend Med. 2012;9:335-47. e2.
15. Sigdel TK, Sarwal MM. Moving beyond HLA: a review of nHLA antibodies in organ transplantation. Hum Immunol. 2013;74:1486-90.
16. McCarroll SA, Bradner JE, Turpeinen H, Volin L, Martin PJ, Chilewski SD, et al. Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet. 2009;41:1341-4.
17. McCaughan JA, McKnight AJ, Maxwell AP. Genetics of new-onset diabetes after transplantation. J Am Soc Nephrol. 2014;25:1037-49.
18. Birdwell KA, Grady B, Choi L, Xu H, Bian A, Denny JC, et al. The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Pharmacogenet Genomics. 2012;22:32-42.
19. Oetting WS, Schladt DP, Leduc RE, Jacobson PA, Guan W, Matas AJ, et al. Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort. Transpl Int. 2011;24:1231-8.
20. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet. 2010;11:499-511.
21. Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda). 2011;1:457-70.
22. Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007;81:1084-97.
23. The Genome of the Netherlands Consortium. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet. 2014;46:818-25.
24. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
25. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One. 2008;3:e3583.
26. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther. 2011;13:101.
27. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012;8:e1002793.
28. Hoffmann TJ, Kvale MN, Hesselson SE, Zhan Y, Aquino C, Cao Y, et al. Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics. 2011;98:79-89.
29. UK Biobank Array Design Group. UK Biobank Axiom Array Datasheet. 2014. Available from: http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UK-Biobank-Axiom-Array-Datasheet-2014.pdf.
30. Affymetrix Inc. Axiom Biobank Genotyping Arrays. 2014. Available from: http://media.affymetrix.com/support/technical/datasheets/axiom_biobank_genotyping_arrays_datasheet.pdf
31. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, et al. A Systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012;335:823-8.
32. ExAC Browser. Available from: http://exac.broadinstitute.org.
33. iGeneTrain. Available from: www.igenetrain.org.
34. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106:9362-7.
35. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42:D1001-6.
36. T G, de Bakker PIW, McVean G, Sabeti PC, Miretti MM, Green T, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet. 2006;38:1166.
37. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5:889.
38. Jia X, Han B, Onengut-Gumuscu S, Chen W-M, Concannon PJ, Rich SS, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One. 2013;8:e64683.
39. Hewett M, Oliver DE, Rubin DL, Easton KL, Stuart JM, Altman RB, et al. PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res. 2002;30:163-5.
40. Jacobson PA, Schladt D, Oetting WS, Leduc R, Guan W, Matas AJ, et al. Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation. Transplantation. 2011;91:309-16.
41. Jacobson PA, Oetting WS, Brearley AM, Leduc R, Guan W, Schladt D, et al. Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. Transplantation. 2011;91:300-8.
42. Jacobson PA, Schladt D, Israni A, Oetting WS, Lin YC, Leduc R, et al. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. Transplantation. 2012;93:624-31.
43. O'Brien RP, Phelan PJ, Conroy J, O'Kelly P, Green A, Keogan M, et al. A genome-wide association study of recipient genotype and medium-term kidney allograft function. Clin Transplant. 2013;27:379-87.
44. Marder B, Schröppel B, Murphy B. Genetic variability and transplantation. Curr Opin Urol. 2003;13:81-9.
45. Goldfarb-Rumyantzev AS, Naiman N. Genetic prediction of renal transplant outcome. Curr Opin Nephrol Hypertens. 2008;17:573-9.
46. Krüger B, Schröppel B, Murphy BT. Genetic polymorphisms and the fate of the transplanted organ. Transplant Rev (Orlando). 2008;22:131-40.
47. Nickerson P. The impact of immune gene polymorphisms in kidney and liver transplantation. Clin Lab Med. 2008;28:455-68.
48. Affymetrix. Available from: www.affymetrix.com.
49. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-75.
50. Sherman deBakker, P. J. TIDGC Immunochip HLA reference Panel [Internet]. Repository NC, editor. 2013. Available from: https://www.niddkrepository.org/studies/t1dgc-special/
51. Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, et al. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology. 2011;53:317-24.
52. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11:1025-30.
53. Pallet N, Jannot A-S, El Bahri M, Etienne I, Buchler M, de Ligny BH, et al. Kidney transplant recipients carrying the CYP3A4 22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. Am J Transplant. 2015;15:800-5.
54. Zuo X, Ng CM, Barrett JS, Luo A, Zhang B, Deng C, et al. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis. Pharmacogenet Genomics. 2013;23:251-61.